The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential development. Unlike shots, this method offers a less invasive way to provide GLP-1 therapies. These https://mariyahvpsh642501.blogcudinti.com/41100090/glp-1-patches-a-new-approach-to-diabetes-treatment